Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News PureTech Health ADR Representing 10 Ord Shs PRTC

Healthcare Biotechnology
PureTech Health plc is a clinical stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company's R&D engine has resulted in the development of around 29 therapeutics and therapeutic candidates, including two that have received both United States Food and Drug Administration (FDA) clearance and European... see more

Recent & Breaking News (NDAQ:PRTC)

PureTech Founded Entity Akili Announces the Results of EndeavorRx(TM) Clinical Study in Pediatric ADHD Published in Nature Digital Medicine

Business Wire March 26, 2021

PureTech Announces Board Member Retirement

Business Wire March 18, 2021

PureTech: Notice of Results

Business Wire March 15, 2021

PureTech to Present at The Barclays Global Healthcare Conference

Business Wire March 3, 2021

PureTech Founded Entity Karuna Therapeutics Announces Pricing of Public Offering of Common Stock

Business Wire March 2, 2021

Vedanta Biosciences to Present at Upcoming Investor Conferences

Business Wire March 2, 2021

PureTech Announces Publication of Glyph(TM) Platform Preclinical Proof-of-Concept Study in Journal of Controlled Release

Business Wire February 25, 2021

PureTech Founded Entity Karuna Therapeutics Announces New England Journal of Medicine Publication of Data from EMERGENT-1 Phase 2 Trial Evaluating KarXT in Schizophrenia

Business Wire February 25, 2021

PureTech to Present at The SVB Leerink 10th Annual Global Healthcare Conference

Business Wire February 18, 2021

PureTech Founded Entity Vor Biopharma Closes Over $200M Initial Public Offering

Business Wire February 10, 2021

PureTech Receives Approximately $118 Million from Sale of Portion of Founded Entity Shares

Business Wire February 10, 2021

PureTech Founded Entity Vedanta Biosciences Appoints Mark Mullikin as Chief Financial Officer

Business Wire February 8, 2021

Vedanta Biosciences Appoints Mark Mullikin as Chief Financial Officer

Business Wire February 8, 2021

PureTech Founded Entity Vor Biopharma Announces Pricing of Initial Public Offering

Business Wire February 5, 2021

PureTech Adds Bharatt Chowrira, PureTech's President and Chief of Business and Strategy, to Board of Directors

Business Wire January 29, 2021

PureTech Founded Entity Vor Announces FDA Clearance of IND Application for VOR33

Business Wire January 14, 2021

Follica Adds Two Leaders in Aesthetic Medicine and Dermatology to Its Board of Directors

Business Wire January 14, 2021

PureTech Founded Entity Follica Adds Two Leaders in Aesthetic Medicine and Dermatology to its Board of Directors

Business Wire January 14, 2021

Vedanta Biosciences Announces $25 Million Investment from Pfizer Inc.

Business Wire January 12, 2021

PureTech Founded Entity Vedanta Biosciences Announces $25 Million Investment from Pfizer Inc.

Business Wire January 12, 2021